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The health of adolescents in detention: a global scoping 
review
Rohan Borschmann, Emilia Janca, Annie Carter, Melissa Willoughby, Nathan Hughes, Kathryn Snow, Emily Stockings, Nicole T M Hill, 
Jane Hocking, Alexander Love, George C Patton, Susan M Sawyer, Seena Fazel, Cheneal Puljević, Jo Robinson, Stuart A Kinner
Adolescents detained within the criminal justice system are afected by complex health problems, health-risk behaviours, 
and high rates of premature death. We did a global synthesis of the evidence regarding the health of this population. We 
searched Embase, PsycINFO, Education Resources Information Center, PubMed, Web of Science, CINCH, Global 
Health, the Cochrane Database of Systematic Reviews, the Campbell Library, the National Criminal Justice Reference 
System Abstract Database, and Google Scholar for peer-reviewed journal articles, including reviews, that reported the 
prevalence of at least one health outcome (physical, mental, sexual, infectious, and neurocognitive) in adolescents (aged 
<20 years) in detention, and were published between Jan 1, 1980, and June 30, 2018. The reference lists of published 
review articles were scrutinised for additional relevant publications. Two reviewers independently screened titles and 
abstracts, and three reviewed full texts of relevant articles. The protocol for this Review was registered with PROSPERO 
(CRD42016041392). 245 articles (204 primary research articles and 41 reviews) were included, with most primary 
research (183 [90%]) done in high-income countries. A high lifetime prevalence of health problems, risks, and conditions 
was reported in detained adolescents, including mental disorders (0–95%), substance use disorders (22–96%), self-
harm (12–65%), neurodevelopmental disabilities (2–47%), infectious diseases (0–34%), and sexual and reproductive 
conditions (pregnant by age 19 years 20–37%; abnormal cervical screening test result 16%). Various physical and mental 
health problems and health-risk behaviours are more common among adolescents in detention than among their peers 
who have not been detained. As the social and structural drivers of poor health overlap somewhat with factors associated 
with exposure to the criminal justice system, strategies to address these factors could help to reduce both rates of 
adolescent detention and adolescent health inequalities. Improving the detection of mental and physical disorders, 
providing appropriate interventions during detention, and optimising transitional health care after release from 
detention could improve the health outcomes of these vulnerable young people.
Introduction
The life trajectories of many adolescents detained within 
the criminal justice system are characterised by en­
trenched disadvantage, instability, abuse, neglect, poor 
education, and poverty.1–3 These social and structural 
drivers of detention overlap to a large degree with the 
determinants of early disease morbidity and mortality. 
Growing evidence suggests that adolescents who have 
been in detention die at a rate that is ive to 41 times 
higher than that of their age­matched and sex­matched 
peers, most often from drug overdose, suicide, injury, or 
violence.4–7 Many detained adolescents also have complex, 
co­occurring health conditions, such as mental disorder8,9 
(including self­harm,10 suicidal behaviour,11 and substance 
dependence),12 cognitive dysfunction and learning 
di culties,13 non­communicable diseases (eg, asthma),14 
and sexually transmitted infections (STIs) and blood­
borne viral infections.15 Many individuals under­utilise 
primary and preventive care in the community,16 such 
that detention often represents the irst meaningful 
opportunity to identify their physical and mental health 
needs and to initiate appropriate health care.
Efective care planning and coordination requires an 
understanding of the prevalence and co­occurrence of 
health problems, but global evidence regarding the health 
of detained adolescents has never been fully synthesised. 
Previous reviews have focused on one health condition 
(eg, mental disorder)8,9 or synthesised evidence across 
health domains for one country.1 The most comprehensive 
review of detained adolescents1 focused solely on US 
studies and was published more than a decade ago. 
In addition to documenting markedly elevated rates 
of morbidity and mortality among this population, 
the authors identiied a high prevalence of health­
compromising behaviours, and a distinct lack of familial 
and community supports to facilitate reintegration into the 
community after release from detention.1 There remains a 
pressing need to synthesise the indings of studies done in 
other settings.17 In this global Scoping Review, we aimed to 
synthesise the evidence regarding the health of adolescents 
detained within the criminal justice system in any country. 
This included both youth and adult criminal justice 
systems, provided that the age criterion was met.
Methods
Overview
We conducted a systematic search to identify literature on 
the health of detained adolescents. Our Scoping Review 
was done in accordance with the Preferred Reporting Items 
for Systematic Reviews and Meta­Analyses Extension for 
Scoping Reviews guidelines.18 The protocol was registered 
with the PROSPERO (number CRD42016041392) before 
the review was done.
Search strategy and selection criteria
We searched 11 electronic databases: Embase, PsycINFO, 
Education Resources Information Center, PubMed, 
Web of Science, CINCH, Global Health, the Cochrane 
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Database of Systematic Reviews, the Campbell Library, 
the National Criminal Justice Reference System Abstract 
Database, and Google Scholar. We used variants and 
combinations of search terms relating to custody or 
detention under the criminal justice system and physical, 
mental, sexual, infectious, and neurocognitive health 
conditions (appendix pp 1–4). All databases were searched 
on March 1, 2017, for entries from Jan 1, 1980, to 
Feb 28, 2017, and the search was updated on July 1, 2018, 
by a rapid review for entries to June 30, 2018. We 
scrutinised the reference lists of published review articles 
to locate additional relevant publications not identiied 
during the database searches. We also corresponded with 
experts in the ield to identify additional publications.
Publication format was limited to peer­reviewed journal 
articles (as a ilter for quality resulting from the peer­
review process), including all types of review publications 
(narrative, systematic, and meta­analysis). The rationale 
for including previous reviews was that scoping reviews 
are designed to identify key themes and trends in the 
literature,19 as opposed to extracting data for meta­
analysis, and previous reviews are valuable sources of 
such themes. We included publications from any country 
and in any language. Publications were deemed eligible 
for inclusion if participants had been detained within the 
criminal justice system. Because not all countries have 
separate youth and adult criminal justice systems and 
the age cutof between youth and adult detention varies 
between countries, publications relating to adolescents 
(aged <20 years, as deined by the UN20 and used in a 
previous large review)9 incarcerated in adult correctional 
institutions were included, if indings were appropriately 
disaggregated by age. Only publications in which all 
participants were younger than 20 years of age at the time 
they were detained, and which reported the prevalence of 
at least one health outcome, were eligible for inclusion. 
Studies were excluded if they reported on health out­
comes in selected samples only (eg, adolescents detained 
in psychiatric hospitals or those referred to health care). 
We also excluded studies that reported knowledge of 
health­risk behaviours or intention to engage in health­
protective behaviours (eg, condom use) but did not report 
on an actual health outcome.
Publication selection
Search results were imported into EndNote X8 reference 
management software and duplicates were deleted. 
Title and abstract screening was done independently by 
two researchers (including EJ). Full­text reviews of 
the remaining publications were then done independently 
by three researchers (including EJ and CP) and reference 
lists of potentially relevant publications were manually 
searched. Uncertainty regarding whether publications 
met the inclusion criteria was resolved through dis­
cussion among the three researchers. In instances when 
the full text of potentially relevant publications could 
not be located, two attempts were made to contact the 
author(s) via email to request a copy.
Quality assessment
The Joanna Briggs Institute Critical Appraisal Checklist for 
Prevalence Studies21 was used to assess the methodological 
quality of all primary research publications by evaluating 
Figure: Study selection profile
*Sample includes people ≥20 years of age (n=120), prevalence not reported 
or could not be determined (n=125), no outcome of interest reported (n=120), 
selected sample (n=164), sample not in youth justice detention or with no 
history of youth justice detention (n=145), sample includes people not in youth 
justice detention or without history of youth justice detention (n=72), poor 
ascertainment or deinition of the outcome (n=28), not a journal article (n=18), 
self-reported delinquency (n=7), unable to conirm detention (n=3), full text not 
found (n=2), sample size too small (n=1).
12 783 records identified by database search
 12 262 from original search 
 521 from rapid update 
7817 records screened by title and abstract
 7274 from original search
 511 from rapid update
 32 from other sources
4998 duplicates removed
 4988 from original search
 10 from rapid update 
32 additional records
 identified through 
 other sources
1106 full-text articles assessed for eligibility
 951 from original search
 123 from rapid update 
 32 from other sources
6711 records that did not meet the inclusion 
  criteria excluded 
 6323 from original search
 388 from rapid update
260 studies assessed for quality
 222 from original search
 10 from rapid update
 28 from other sources
41  reviews not assessed
805 records excluded*
 696 from original search
 109 from rapid update
245 studies included
201 from original search
12 from rapid update
32 from other sources
56 studies excluded on quality
 54 from original search 
 2 from rapid update
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the extent to which they addressed the possibility of bias in 
nine areas of study design, conduct, and analysis. Each of 
the nine domains received a score from 0 (poor quality) 
to 2 (high quality), and a total quality score was calculated 
by summing the individual domain scores. Total scores 
ranged from 0 to 18, with higher scores indicating higher 
quality. Studies with a total score of less than 13 were 
excluded. Four researchers (EJ, CP, MW, AL) independently 
assessed each included publi cation and any uncertainty 
regarding the quality of publications was resolved through 
discussion among them.
Role of the funding source
The funder of the study had no role in study design, data 
collection and analysis, decision to publish, or prep­
aration of the manuscript.
Results
The search yielded 12 815 articles (12 262 from the 
original database search, 521 from the rapid update, and 
32 from other sources; igure), of which 7817 remained 
after duplicates were removed. A further 6711 articles 
were removed after title and abstract screening. The full 
texts of the remaining 1106 articles were screened, 
including 47 articles that were translated into English for 
the purposes of this review: 13 from Spanish, 11 from 
German, six from French, four from Portuguese, three 
from Japanese, two from Chinese, two from Croatian, 
two from Italian, and one each from Danish, Dutch, 
Persian, and Russian. Of the full­text articles screened, 
805 were excluded, leaving 301 articles: 260 primary 
research articles and 41 reviews. 56 (22%) primary 
research articles were excluded after assessment for 
quality (48 from high­income countries and eight from 
low­income and middle­income countries [LMICs]). The 
inal review comprised 204 primary research articles and 
41 reviews. Most primary research articles (183 [90%]) 
came from high­income countries and the remaining 
21 (10%) came from LMICs. Findings are presented here, 
grouped into six key health domains: mental disorders 
(excluding substance use disorders), self­harm and 
suicidal behaviour, substance use and substance use 
disorders, neurodevelopmental disabilities, blood­borne 
viruses and STIs, and sexual and reproductive health.
Mental disorders
90 publications, including 18 reviews, reported on mental 
disorders in detained adolescents (table 1). 47 (52%) 
were done in the USA and 18 (20%) in LMICs. Detained 
adolescents had a markedly higher prevalence of mental 
disorders than their community peers.22,23 One USA­based 
review of the health of detained adolescents2 reported that 
66·8% of male and 81·0% of female adolescents met 
the diagnostic criteria for at least one mental disorder, 
with depression, behavioural disorders, and substance 
use disorders being the most prevalent. The reported 
point prevalence of any anxiety disorder in detained 
adolescents ranged from 3·4% to 31·5% for males (mean 
17·4% [SD 8·1]; 17·8% [IQR 11·9–22·1])24,25 and from 
20·9% to 59·0% in females (31·9% [11·6]; 30·3% 
[26·0–31·4]; appendix p 6).24,26,27 The reported point 
prevalence of post­traumatic stress disorder ranged from 
0·0% to 53·0% for males (17·4% [14·1]; 14·1% 
[9·0–24·5])28–30 and from 13·0% to 65·1% for females 
(27·5% [17·2]; 20·0% [14·7–35·0]).28,30,31 Of the 14 papers 
that investigated psychotic disorders, the reported point 
prevalence of any psychotic disorder ranged from 0·8% 
to 2·0% for males (1·4% [0·6]; 1·3% [1·0–2·0])22,26,32 and 
from 1·0% to 9·0% for females (2·8% [3·1]; 1·5% 
[1·0–3·0]).22,32,33
Mood disorders were also highly prevalent among 
detained adolescents, with a reported point prevalence 
of any depressive disorder ranging from 4·0% to 36·0% 
for males (22·4% [14·2]; 26·2% [5·8–36·0])29,31,32 and from 
14·0% to 63·0% for females (39·2% [16·8]; 33·3% 
[28·0–51·8]),31,32,34 and major depressive disorder ranging 
Point prevalence in detained adolescents, %* Lifetime prevalence 
in detained 
adolescents, %
Lifetime 
prevalence in 
adolescents in 
the general 
population, %
Males Females
Mood disorder (any) 10·1% (4·0–14·0); 0·4–36·0%a1–a19 26·6% (15·8–33·3); 0·0–63·0%a2–a4,a6,a8,a9,a12,a13,a18,a20–a25 7·0–82·0%a6,a26–a29 14·3%a30
Major depressive disorder 10·8% (6·7–11·4); 0·9–14·0%a4–a7,a10,a11,a15,a16 7·4–36·0%a4,a6,a22† 4·7–40·4%a9,31–a35 1·3%a36
Anxiety disorder (any) 17·8% (11·9–22·1); 3·4–31·5%a2,3,a6,a13–a19,a23,a37 30·3% (26·0–31·4); 20·9–59·0%a2,a3,a6,a13,a22,a25,a27,a38 9·0–56·3%a5,a27,a29,a39,a40 6·5%a36
Post-traumatic stress disorder 14·1% (9·0–24·5); 0·0–53·0%a5–a8,a10,a11,a15,a16,a18,a23,a27,a37,a41–a47 20·0% (14·7–35·0); 13·0–65·1%a8,a20,a23,a27,a41–a43,a45 11·0–48·9%a9,a28,a33,a43 5·0%a30
Obsessive-compulsive disorder 4·9% (2·6–7·0); 0·4–9·0%a5,a6,a15,a16 2·0–7·4%‡a5,a6,a15,a16,a20,a35 0·4–9·0%a5,a6,a16,a20,a48 0·3–4·0%a49
Conduct disorder 73·5% (53·9–79·8); 26·0–95·0%a3–a8,a10–a12,a15–a17,a19,a34,a37,a41,a42,a50–a52 53·8% (43·1–77·5); 17·0–91·0%a3,a4,a6,a8,a12,a20–a22,a34,a41,a42,a53 13·9–100%a33,a40,a54–a56 2·1%a36
Oppositional defiant disorder 19·3% (14·5–48·0); 8·0–51·0%a3,a6,a8,a12,a16,a41,a57 39·7% (25·0–46·4); 17·5–62·0%a3,a6,a12,a21,a22,a41 7·6–22·4%a35,a39,a58,a59 3·6%a36
Schizophrenia 2·0%; 0·8–2·2%a5,a6,a51§ 1·9%a6¶ 2·2–4·0%a34,a60 0·5–1·5%a61
For references see appendix (pp 15–29). *Unless otherwise specified, data are median (IQR); range. †Reported as range only, as n=3. ‡Reported as range only, as n=2. §Reported as median; range only as n=3. 
¶Reported as point estimate only, as n=1.
Table 1: Prevalence of mental disorders in adolescents in detention and in the general population
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from 0·9% to 14·0% for males (9·1% [4·2]; 10·8% 
[6·7–11·4])35–37 and from 7·4% to 36·0% for females 
(24·2% [14·9]; 29·2% [7·4–36·0]; appendix p 7).
The reported point prevalence of conduct disorder 
ranged from 26·0% to 95·0% for males (66·9% [18·7]; 
73·5% [53·9–79·8]),28,35,38–40 and from 17·0% to 91·0% 
for females (57·1% [22·0]; 53·8% [43·1–77·5]; appendix 
p 8),26,41–44 and the reported point prevalence of oppositional 
deiant disorder ranged from 8·0% to 51·0% for males 
(26·9% [17·1]; 19·3% [14·5–48·0]),26,28,29,37,38 and from 
17·5% to 62·0% for females (38·4% [15·8]; 39·7% 
[25·0–46·4]; appendix p 8).22,26–28,38,44
Self-harm and suicidal behaviour
56 articles, including four reviews, reported on suicidal 
ideation (n=36), self­harm or suicide attempt (n=27), and 
suicide deaths (n=7). Almost all original studies (n=50; 
96%) came from eight high­income countries (the USA, 
Canada, the UK, Germany, Belgium, Russia, Australia, 
and New Zealand), with just six (11%) studies coming 
from LMICs (Sri Lanka, Iran, and Jordan; table 2). 
Five studies reported composite suicide risk scores con­
sisting of suicide ideation and attempt.35,44–47 Two studies 
com pared suicide rates between detained adolescents 
and their community peers,6,48 and one study compared 
rates of suicidal ideation between detained adolescents 
and their community peers.49 Few studies compared rates 
of suicidal behaviour between detained adolescents and 
their community peers.50 Overall, the prevalence of 
suicidal behaviour was markedly higher among detained 
adolescents than among adolescents in the general 
population.51–56 In detained adolescents, the prevalence of 
suicidal ideation ranged from 12·7% to 59·0% over the 
lifetime,57–60 2·9–30·6% during the past month,25,28,61–64 
2·2–80·0% during the past 6 months,47,65,66 and 
15·4–58·1% during the past year67 (appendix p 9);68 and 
the lifetime prevalence of suicide attempts ranged from 
4·0% to 29·4% for males (mean 16·8% [SD 7·1]; median 
17·3% [IQR 12·2–20·9])15,40,41,54,59,61,62 and from 
20·8% to 51·1% for females (37·3% [10·6]; 39·8% 
[25·4–43·0]).40,41,59,65 For both sexes combined, the 
prevalence of suicide attempts was 1·9–6·6% during 
the past month and 13·3–35·0% during the past 
year (appendix p 10).11,28,29,41,45,57–64,66,67,69–81 The prevalence 
Lifetime prevalence in detained adolescents (%)* Lifetime prevalence in 
adolescents in the 
general population (%)
Suicidal ideation ·· 15·3%a69
Males
Lifetime 19·0% (14·1–24·7); 12·7–33·0%a41,a62–a65 ··
Past month 8·6% (8·0–9·6); 7·0–11·6%a15,a41,a66–a68 ··
Females
Lifetime 38·3% (29·1–49·0); 21·6–58·0%a41,a62–a64 ··
Past month 6·0–30·6%a41,a68† ··
Suicide attempt‡ ·· 4·1%a75
Males 17·3% (12·2–20·9); 4·0–29·4%a15,a41,a42,a57,a62,a64,a65,a67,a68,a70–a72 ··
Females 39·8% (25·4–43); 20·8–51·1%41,a42,a62,a68,a71,a73,a74 ··
Self-harm§ ·· 10·5–16·9%a76,a77
Males 20·9% (20·0–25·0); 12–34%a41,a42,a57,a60,a71 ··
Females 47·1% (40·5–58·1); 38·0–65·0%a41,a42,a60,a71 ··
Suicide¶ 17·6–32%a78,a79 6·0–7·8%a80,a81||
For references see appendix (pp 15–29). *Unless otherwise specified, data are median (IQR); range. †Reported as range 
only. ‡Defined as a suicide attempt with intent to die. §Defined as deliberate self-harm and self-injurious behaviour. 
¶Proportion of overall mortality due to suicide. ||Aggregated estimates for ages 10–24 years.81
Table 2: Prevalence of lifetime suicidal behaviour in adolescents in detention and in the general 
population
Prevalence in detained adolescents (%) Time period for past use* Lifetime 
prevalence in 
adolescents in 
the general 
population (%)
Alcohol 50·9–90·1%a13,a82–a85 Past 1–12 months 6·0–45·0%a30
Cannabis 45·0–80·4%a13,a82,a83,a86–a90 Past 3 days to 12 months 6·0–42·0%a91,a92
Amphetamines (including methamphetamine) 8·2–25·8%a85,a89,a93–a95 Past 30 days to 3 months 0·0–12·0%a92,a96
Crack cocaine 1·5–15·2%a88,a93,a97 Past 1–4 months 0·7–2·7%a92
Cocaine (powdered or unspecified) 5·4–37·0%a88,a89,a97,a98 Past 3 days to 3 months 1·0–9·0%a30,a96
Heroin 1·0–6·5%a86,a88,a97 Past 3 days to 4 months 0·0–1·0%a30,a96
Inhalants 4·3–14·3%a87,a89,a93,a97 Past 4–6 months 8·0–11·0%a92,a96†
Any substance use disorder ·· ·· 7·0–11·0%a30,a101,a102
Males 50·7% (49·9–60); 11·0–85·5%a6,a12,a41,a99,a100§ NA ··
Females 59·4% (45·0–75); 12·0–100·0%a6,a12,a41,a42,a99,a100§ NA ··
Any substance use disorder (excluding alcohol use)† 9·4–60·0%a10,a99,a100,a103–a106 NA 4·3–5·5%a102
Alcohol use disorder 5·2–77·4%a33,a48,a59,a103,a106–a109 NA 4·6–6·0%a102
Cannabis use disorder 7·5–83·4%a6,a12,a59,a103,a106,a109,a110 NA 3·1–3·9%a102
For references see appendix (pp 15–29). *Includes time before detention or time before interview. †Includes opiate abuse and dependence. ‡Includes amphetamine, cocaine, 
hallucinogen, inhalant, opiate, and sedative use disorders. §Reported as median (IQR); range.
Table 3: Prevalence of use of specific substances in adolescents in detention and in the general population
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of suicidal behaviour during detention ranged from 
4·6% to 22·9%,11,67,70,81,82 and increased to 6·0–27·5%77,78 
following release from detention. The most commonly 
reported methods of self­harm were cutting (26–52%), 
poisoning (23·8–75%), and hanging or strangulation 
(9·5–67%; see appendix [p 11] for combined self­harm 
indings).57,59,78 Although suicide accounted for ≤1% of all 
deaths among adolescents in detention,11,74,83 the risk of 
suicide following release from detention is estimated to 
be two to nine times greater than that of their age­matched 
and sex­matched peers.6,11,48,82,84
Substance use and substance use disorders
90 publications, including 12 reviews, reported on 
substance use. 80 (89%) publications came from 
high­income countries. A large proportion of detained 
adolescents reported using illicit substances within the 
past year,12 including cannabis,64,85 cocaine,86 amphet­
amines,87 heroin,88 hallucinogens,86,88,89 and inhalants,86 
in addition to using alcohol64,85,90 and tobacco91 (table 3). 
Few studies measured the frequency of use or quantity 
of speciic substances used. In studies that measured 
tobacco use, almost all detained adolescents reported 
lifetime use.88,89,91,92 Few studies used validated screening 
tools to measure tobacco use, and few informative 
comparisons could be made between detained and 
non­detained adolescents. The reported prevalence of 
lifetime substance use disorder ranged from 22% to 
96% for detained adolescents, in contrast to 7–11% 
for adolescents in the general population (appendix 
p 12).37,93 The reported prevalence of lifetime injecting 
drug use among detained adolescents ranged from 0·1% 
to 55% (appendix p 12).90,94 Established risk factors for 
substance use—including maltreatment early in life, 
unstable and dysfunctional family environments, peer 
and family substance use, and brain injury—were 
more common among detained adolescents than their 
community peers.95
Neurodevelopmental disabilities
58 publications, including 12 reviews, reported on neuro­
developmental disorders. 45 (78%) came from high­
income countries. The reported prevalence of various 
neuro developmental disabilities among detained ado ­
lescents was higher than that among their community 
peers (table 4). Reported rates of learning di culties 
among detained adolescents ranged from 10% to 32%,96–100 
relecting varied deinitions and assumptions nece ssitated 
by an inability to perform full diagnostic testing. However, 
these rates are considerably higher than those reported in 
general population studies (table 4).101,102 Similar indings 
were reported for communication impairments, with 
evidence suggesting that a majority of detained adolescents 
had some form of di culty with language that signiicantly 
afected their day­to­day functioning.103,104 Experiences of 
traumatic brain injury were common among detained 
adolescents. One recent review suggested that 32–50% of 
detained adolescents had had a traumatic brain injury that 
resulted in loss of consciousness during their childhood, 
compared with 5–24% of adolescents in the general 
population.13
Rates of attention­deicit hyperactivity disorder (ADHD) 
in the general population of children and adolescents are 
estimated to be between 3% and 9%, with the prevalence 
in males approximately four times greater than that 
among females.105 In contrast, among individuals in 
detention, the prevalence of ADHD has been reported to 
range from 2·3% to 49·1% for males (mean 20·2% 
Diagnostic criteria and typical symptoms Reported prevalence in 
detained adolescents, %
Reported prevalence in adolescents 
in the general population, %
Attention-deficit hyperactivity 
disorder
Persistence in multiple symptoms of inattention, 
hyperactivity, and impulsivity
2–50%a4,a111 3–9%a36,a112
Communication impairments Problems with speech, language, or hearing that 
significantly affect academic achievement or 
day-to-day social interactions; includes expressive 
and receptive language, speech sound disorder, 
and stuttering
60–65%a113–a115 5–7%a113
Fetal alcohol spectrum disorder Reduced height, weight, or head circumference; 
characteristic facial features; deficits in executive 
functioning, memory, cognition, intelligence, 
attention, or motor skills; resulting from prenatal 
alcohol exposure due to maternal consumption 
during pregnancy
11–21%a116–a120 2–5%a120
Learning disability Deficits in cognitive capacity (measured by an IQ score 
of <70); occasionally with adaptive functioning 
(significant difficulties with everyday tasks)
10–32%a56,a121–a124 2–4%a125
Traumatic brain injury Disruption to the normal function of the brain 
resulting from a force to the head that causes loss of 
consciousness
32–50%a126,a127 15–20%a128–a130
For references see appendix (pp 15–29).
Table 4: Prevalence of neurodevelopmental disabilities in adolescents in detention and in the general population
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[SD 12·8]; median 17·6% [IQR 11·7–24·6])9,22,25,26,30,32,35–38,79,106–109 
and from 6·0% to 48·2% for females (26·7% [12·7]; 
21·7% [18·5–37·3]).9,22,24,27,30,38,39,42,44,69 Although some evi­
dence indicates a higher prevalence of autism spectrum 
disorder among incarcerated young people than among 
the general population,110 previous studies have used 
selected samples, making prevalence di cult to establish.
The prevalence of fetal alcohol spectrum disorder 
(FASD) was also higher among detained adolescents 
than in the general population. Four Canadian studies 
documented a prevalence of 11–23% in detained 
adolescents,111–114 and an Australian study published in 
2018 reported a prevalence of 36%.115 By contrast, in the 
general populations of high­income countries, 2–5% of 
children are estimated to be born with FASD.116 Each of 
the aforementioned studies from Australia and Canada 
reported an especially high prevalence among detained 
Indigenous adolescents (19–47%), which is relective of 
wider health inequalities and dis parities.117 The scarce 
research on FASD, which was restricted to studies 
from Canada and Australia, is indicative of the geographi­
cally uneven spread of studies of childhood neuro­
developmental disabilities in general, with little evidence 
available from detained adolescents in LMICs.
Blood-borne viruses and sexually-transmitted 
infections
66 publications, including 12 reviews,1,2,15,118–126 reported on 
blood­borne viruses and STIs in detained adolescents 
(table 5). 41 (76%) of the 54 original studies were done in 
the USA, with the remainder from Australia (n=3), Canada 
(n=2), Iran (n=2), Brazil (n=1), Bulgaria (n=1), Pakistan 
(n=1), Tanzania (n=1), Russian (n=1), and six nations in 
the eastern Caribbean (n=1). The prevalence data from 
these studies are presented in the appendix (p 13).
Detained adolescents had an increased prevalence of 
many communicable diseases, STIs, and associated risk­
taking behaviours (eg, unprotected sex, sharing injecting 
equipment) compared with their community peers.2,85,127,128 
34 original studies reported chlamydia or gonorrhoea 
prevalence, 31 (91%) of which were done in the USA. 
Evidence on the prevalence of syphilis among detained 
adolescents was sparse, as syphilis is markedly less 
prevalent than chlamydia, and gonorrhoea and is less 
often the target of routine screening.124,125 We identiied 
ive studies that reported syphilis prevalence, seven 
studies on hepatitis B virus (HBV) surface antigen 
prevalence, 12 studies on hepatitis C virus (HCV) anti­
body prevalence, and 15 on HIV prevalence.
Sexual and reproductive health
18 publications, including three reviews,1,124,129 reported on 
sexual and reproductive health outcomes (table 6). 
13 (87%) primary studies came from the USA and all 
studies provided data about pregnancy among detained 
female adolescents. The reported proportion of detained 
female adolescents who had ever been pregnant ranged 
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from 20% to 37%.27,43,66,86,130–135 Two studies reported that 
between 2% and 6% of detained females were currently 
pregnant,14,124 and one US study indicated that pregnancy 
was the focus of 1·1 health­care visits per detained female 
per month (range 0–6 visits).136 Another study reported 
that 11% of young female detainees had at least one child.86 
Three studies reported that 22–31% of detained adolescent 
males had ever been responsible for a pregnancy.132,134,137 
Seven papers documented the respondents’ reported age 
of sexual debut; six studies reported an average age of 
12–13 years,27,66,130–133 while one reported a range from 
8 years to 13 years of age.137 No corresponding normative 
data could be located for non­detained children and 
adolescents of this age. Three studies27,66,131 reported the 
prevalence of con traception use and showed lower 
frequencies of regular contraception use and of condom 
use during the most recent sexual encounter among 
detained adolescents than among the general population.138 
Two studies reported on the prevalence of pelvic inla­
mmatory disease among females, with estimates ranging 
from 3% to 12%.66,130 Three studies reported the prevalence 
of other genital or pelvic symptoms, including sores on 
the penis or pain during urination in males (38%), and 
dys menorrhoea (68%) or an abnormal cervical screen 
(16%) in females.130,135,137
Discussion
To our knowledge, this is the irst attempt to synthesise 
evidence from a broad and diverse global literature 
examining the health of detained adolescents. Our indings 
show that detained adolescents commonly experience 
poor health across a range of physical and mental 
health domains, including mental disorders, self­harm 
and suicidal behaviour, substance use disorders, neuro­
developmental disabilities, blood­borne viruses and STIs, 
and sexual and reproductive health. In studies that 
permitted a comparison with non­detained adolescents, 
adolescents in detention had consistently poorer health 
proiles. Although dominated by literature from high 
income countries (particularly the USA), the indings were 
broadly consistent across high­income, middle­income, 
and low­income countries and, when viewed from a 
public health perspective, present both challenges and 
opportunities.139,140
Many adolescents under­utilise primary and preventive 
care in the community before detention.16 Although this 
is true in high­income countries,16 no comparable data 
exist from low­income countries, although it is likely 
that high levels of unmet need also exist in such 
settings. Accordingly, detention often provides vulnerable 
adolescents with unique (yet regrettable) opportunities 
for diagnosis, disease management education, medical 
treatment, and coun selling that they might otherwise not 
have accessed in the community.140 For example, our 
indings indicate that detained adolescents have a 
markedly higher prevalence of mental disorders22,23 and 
suicidal behaviours6,48 than their community peers. Most 
detained adolescents with mental disorders return to the 
community after release from detention, and poorer 
mental health is associated with higher rates of 
recidivism.139 As such, timely identiication and 
subsequent provision of appropriate mental health care 
in adolescent detention settings has the potential to 
simultaneously improve mental health outcomes after 
release from detention and reduce rates of re­
incarceration. Detained adolescents with a history of 
suicidal behaviours are an especially at­risk group, with a 
high prevalence of mental and substance use disorders 
and social risk factors.10 They could beneit from targeted 
mental health interventions speciically designed 
to address impulsivity while in detention, as well as 
transitional mental health care and post­release support.
Targeted, evidence­based preventive eforts are urgently 
needed to address the health and social determinants of 
adolescent detention, and to provide timely health care to 
this highly marginalised population.1 For example, illicit 
substance use, by deinition, involves illegal behaviours 
(ie, buying and possessing illicit drugs) which can increase 
the risk of contact with the criminal justice system and 
subsequent detention. In parallel with eforts to recognise 
substance use as a health issue rather than a criminal 
justice issue,141 increased access to developmentally appro­
priate harm reduction and drug treatment services in the 
community could simultaneously improve health 
outcomes and reduce criminal justice system contact 
among adolescents who engage in problematic substance 
use. Similar services should also be made available to 
adolescents in detention, with evidence indicating that 
motivational interviewing can be an efective intervention 
for reducing substance use in detained adolescents.142 
The pharmacological efects of some substances, notably 
alcohol and amphetamines, can increase the likelihood of 
involvement in violent behaviour.143 Additionally, substance 
misuse can interfere with an adolescent’s successful 
transition to adult roles, including educational attainment 
Detained adolescents Adolescents in the general 
population
Age at sexual debut, years (range of mean age) 12·6–13·9a22,a153,a186–a189 16·0–17·0a190,a191
Ever pregnant (females only) 20·3–36·9%a22,a53,a89,a153, 
a186–a189,a192,a193
5·0–10·1%a194*,a195†
Currently pregnant (females only) 2·1–7·5%a186,a196,a197 0·1–5·7%a198‡
Fathered a child or responsible for a pregnancy 
(males only)
22·0–31·0%a188,a192,a199 ··
Regular contraception use 66·1–79·3%a22,a186 89·9%a200§
Used condom during last sexual encounter 33·3%a187 53·8%a201
Ever had pelvic inflammatory disease 3·4–12·0%a153,a186 2·9%a202¶
For references see appendix (pp 15–29). *Based on proportion of 15–20-year-old women reporting ever pregnant in 
population-based study in Switzerland. †Based on proportion of 16–69-year-olds who reported a pregnancy at 
≤20 years in population-based study in Australia. ‡Based on annual adolescent pregnancy rate in high-income 
countries. §Any contraception use last sex (US national data). ¶Prevalence of reported lifetime pelvic inflammatory 
disease among 18–24-year-olds (US national data).
Table 6: Prevalence of sexual and reproductive health outcomes in adolescents in detention and in the 
general population
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and workforce participation, which can increase the likeli­
hood of further detention.144 Reco mmendations to address 
harmful substance use embedded within deten tion 
settings include routine screening of all detained ado­
lescents to identify harmful substance use and dependence 
as early as possible, provision of appropriate evidence­
based harm reduction and drug treatment services, and 
comprehensive transitional support during re­entry 
into the community.145 In addition to measuring route of 
administration, important parameters to measure in 
substance use research with detained adolescents include 
frequency of use and quantity used, which are strongly 
correlated with drug­related harms. However, few studies 
in our Review included such data.
Our indings highlight a higher prevalence of several 
neurodevelopmental disabilities among detained ado­
lescents when compared with their non­detained peers.101–104 
Consideration must be given to the mechanisms by which 
cognitive, communicative, or socio­emotional di culties 
associated with neurodevelopmental disabilities increase 
the risk of persistent ofending and eventual deten­
tion.146 Insuicient awareness or assessment of neuro­
developmental disability can lead to a failure to understand 
important potential inluences on antisocial behaviour or 
causes of poor engagement in interventions intended 
to address or reduce recidivism. Neuro developmental 
disability is also a risk factor for other health di culties, 
including self­harm and substance misuse.147 Bespoke 
interventions supporting developmental needs that are 
well evidenced in other settings should also be employed 
within criminal justice settings such as adolescent 
detention facilities.3
Detention provides an opportunity to initiate treatment 
for myriad health conditions, such as catch­up vaccinations 
to protect against HBV.148 The wide variation in the 
seroprevalence of HBV and HCV observed in our Scoping 
Review probably relects diferences in both background 
pre valence, population immunisation policies, and 
criminal justice policies in diferent settings. Although a 
low prevalence of HBV and HCV among detained 
adolescents indicates a need for evidence­based prevention 
strategies, any non­zero prevalence indicates that detention 
facilities are important sites for diagnosis and treatment. 
Similarly, two reviews included in our Scoping Review118,125 
do cumented that HIV infection was rare among detained 
adolescents in high­income countries, despite early sexual 
debut and unsafe sex being commonly reported. This 
inding highlights important opportunities for education 
and HIV prevention during detention for adolescents at 
increased risk of these outcomes.118,125 Detained adolescents 
are more likely than their non­detained peers to report an 
early age of sexual debut,149 and previous research has 
shown an association between early sexual debut and 
subsequent exposure to the criminal justice system,150,151 
probably relecting the shared social risks associated with 
these two outcomes. Routine screening for chlamydia and 
gonorrhoea for adolescents in detention is recommended 
by the US Centers for Disease Control and Prevention.152 
The high prevalence of chlamydia among detained 
adolescents, as shown in our Scoping Review, underscores 
the importance of routine STI screening in detention 
facilities, which could also create opportunities for 
engagement around broader elements of sexual and 
reproductive health. Additionally, the high prevalence of 
pelvic inlammatory disease66,130 increases the risk of 
reproductive complications in this population in the 
future. Several studies have shown that high proportions 
of young detained females have experienced childhood 
sexual abuse or intimate partner violence,77,153 suggesting a 
need for trauma­informed approaches to sexual health 
(eg, allowing self­collected specimens rather than pairing 
STI screening with gynaecological examinations, and 
being able to request examination by a doctor of the same 
gender)130 in this population.
We documented a high prevalence of current (2–7%) 
and previous (20–37%) pregnancies in detained adolescent 
females and a high proportion of adolescent males who 
had fathered a child or been responsible for pregnancy 
(22–31%), all of whom were teenagers when they com­
menced their current detention. When considered in 
conjunction with the high rates of substance use disorders, 
including risky alcohol use, this high prevalence of 
pregnancy during adolescence in creases the likelihood of 
intergenerational transmission of conditions such as 
FASD and perinatal substance dependence. Prevention 
eforts for such disorders should be focused on the most 
at­risk and disadvantaged groups in society (including 
detained adolescents, both males and females), and of 
increasing awareness of pregnancy and its prevention 
and providing access to condoms and other efective 
contraception, such as long­acting reversible contra­
ceptives.
Addressing the unmet health­care needs of detained 
adolescents is an issue at the nexus of criminal justice 
reform and health­care reform.2 In light of our indings, 
eforts to better understand the physical and mental health 
trajectories of detained adolescents, and how these 
trajectories might be altered to improve morbidity 
outcomes and reduce mortality risk, should be considered 
an urgent priority. Such opportunities exist in research, 
clinical care, medical education, policy, and advocacy to 
drive improvements in the health of adolescents who have 
been detained. Diverting adolescents from detention and 
into treatment where appropriate, and addressing the 
health needs of those already detained, are crucial goals to 
protect adolescents and their families from further 
adverse health and social outcomes.2 Providing additional 
support to adolescents at increased risk of being exposed 
to the criminal justice system is likely to contribute to a 
reduction in the number of adolescents being detained. 
Furthermore, eforts to improve the health of adolescents 
at increased risk is likely to contribute to improvements in 
public health (because almost all incarcerated adolescents 
return to the community) and public safety (arising from 
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the lower recidivism rates associated with improvements 
in health).139 These efects, in turn, will probably result in 
economic beneits by reducing the burden on both the 
health and criminal justice systems, and confer beneits for 
the next generation of at­risk children and adolescents.154
Our study also shows the limitations of the literature in 
this ield. First, we identiied large knowledge gaps 
relating to domains with signiicant ramiications for 
health, including asthma (no studies), rheumatic heart 
disease (no studies), and dental health (we identiied a 
single cross­sectional study from Brazil examining the 
oral health of 102 detained male adolescents).155 Second, it 
is apparent that this is a relatively new area of 
research; all 241 included studies were published between 
1980 and 2018, with 233 (97%) published since the 
year 2000. This recent increase in research on the health 
of detained adolescents is encouraging, but much work 
remains to be done. Third, most studies in our Scoping 
Review (90% of original research studies and 100% of 
reviews) came from high­income countries, with a 
majority from the USA. More robust, independent 
research examining the health of detained adolescents in 
LMICs is urgently needed. Fourth, more than one in 
ive studies (22%) that met inclusion criteria were deemed 
to be of poor quality and were subsequently excluded. The 
2016 Lancet Commission on Adolescent Health and 
Wellbeing156 called for the urgent collection of more high­
quality data on the health of socially and economically 
marginalised adolescents, including those who come into 
contact with the criminal justice system. Similarly, the 
2017 Lancet Inclusion Health series identiied incarcerated 
young people as a particularly at­risk group, and called for 
more high­quality research on their health and 
wellbeing.157,158 Fifth, males made up a large proportion of 
all primary research study samples, while fewer data on 
the health of detained adolescent girls were available. 
Finally, we were unable to produce pooled regional or 
global prevalence estimates because of the large 
heterogeneity observed in study designs included in the 
Review.
Detained adolescents have poor health proiles across a 
variety of domains. Complex health needs in these 
adolescents are common and are often set against a 
backdrop of entrenched disadvantage. Many of the 
antecedents of poor health in this population are strongly 
linked to criminal justice involvement, such that policies 
regarding adolescent detention are relevant to health 
equity at the population level.159 More high­quality data, 
especially from LMICs, are urgently needed to inform 
targeted, evidence­based preventive strategies to address 
the social and structural drivers of adolescent detention 
and to provide timely health care to this highly 
marginalised group. Concurrent initiatives to reduce 
adolescent detention are crucial and must be made in 
parallel with proportionate investment in alternative ways 
of identifying and addressing their unmet health needs in 
the community. Eforts to better understand and improve 
the physical and mental health trajectories of detained 
adolescents, and how these trajectories might be altered to 
improve health and reduce mortality, will contribute to an 
improvement in broader public health.139 In the interim, 
greater investment in routine, com prehensive screening 
of all adolescents entering detention, coupled with 
evidence­based treatment in detention settings, will help 
to reduce the burden of preventable disease in these 
marginalised young people. As many of the health 
conditions experienced by detained adolescents are 
carried into the community127—with clear implications for 
population public health, appropriate access to transitional 
health care and social support needs to be continued in 
the community following release from detention to ensure 
that the improvements in health that are frequently 
reported during detention are not lost following release.
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